Quan Jin

829 total citations
33 papers, 694 citations indexed

About

Quan Jin is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Epidemiology. According to data from OpenAlex, Quan Jin has authored 33 papers receiving a total of 694 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 8 papers in Pathology and Forensic Medicine and 8 papers in Epidemiology. Recurrent topics in Quan Jin's work include Liver Disease Diagnosis and Treatment (7 papers), Alcohol Consumption and Health Effects (6 papers) and Liver physiology and pathology (5 papers). Quan Jin is often cited by papers focused on Liver Disease Diagnosis and Treatment (7 papers), Alcohol Consumption and Health Effects (6 papers) and Liver physiology and pathology (5 papers). Quan Jin collaborates with scholars based in China and United States. Quan Jin's co-authors include Li‐Hua Lian, Ji‐Xing Nan, Yan‐Ling Wu, Min Jiang, Ben‐Wen Cui, Lin Huang, Chunping Qiao, Yue Shang, Xia Li and Yu Zhang and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, Scientific Reports and British Journal of Pharmacology.

In The Last Decade

Quan Jin

33 papers receiving 690 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Quan Jin China 19 366 159 106 92 73 33 694
Xiaohan Zhai China 16 362 1.0× 142 0.9× 101 1.0× 92 1.0× 61 0.8× 31 745
Chengmu Hu China 18 387 1.1× 201 1.3× 117 1.1× 72 0.8× 44 0.6× 33 848
Ting Bai China 18 351 1.0× 199 1.3× 181 1.7× 124 1.3× 120 1.6× 26 826
Shuang Ren China 13 364 1.0× 104 0.7× 131 1.2× 42 0.5× 74 1.0× 32 757
Jaime Arellanes‐Robledo Mexico 18 361 1.0× 234 1.5× 77 0.7× 116 1.3× 139 1.9× 52 822
A Mahli Germany 12 193 0.5× 158 1.0× 126 1.2× 71 0.8× 60 0.8× 21 472
Amro El‐Karef Egypt 16 236 0.6× 174 1.1× 164 1.5× 82 0.9× 152 2.1× 24 681
Wenwen Wang China 17 329 0.9× 214 1.3× 143 1.3× 89 1.0× 128 1.8× 32 932
Qichao Hu China 16 412 1.1× 212 1.3× 190 1.8× 63 0.7× 48 0.7× 43 1.0k

Countries citing papers authored by Quan Jin

Since Specialization
Citations

This map shows the geographic impact of Quan Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Quan Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Quan Jin more than expected).

Fields of papers citing papers by Quan Jin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Quan Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Quan Jin. The network helps show where Quan Jin may publish in the future.

Co-authorship network of co-authors of Quan Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Quan Jin. A scholar is included among the top collaborators of Quan Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Quan Jin. Quan Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ao, Lijiao, Daquan Li, Sai T. Chu, et al.. (2025). Visual quantitative point-of-care immunoassay based on signal transduction amplification and hue-recognition analysis. Biosensors and Bioelectronics. 279. 117397–117397. 2 indexed citations
2.
Zhang, Jialing, et al.. (2023). Protein profiles reveal MSH6/MSH2 as a potential biomarker for hepatocellular carcinoma with microvascular invasion. Hepatology Research. 54(2). 189–200. 3 indexed citations
3.
Jin, Quan, et al.. (2022). Circular RNA circKIF2A Contributes to the Progression of Neuroblastoma Through Regulating PRPS1 Expression by Sponging miR-377-3p. Biochemical Genetics. 60(4). 1380–1401. 8 indexed citations
4.
Zhan, Fangbiao, et al.. (2022). DYRK2 downregulation in colorectal cancer leads to epithelial–mesenchymal transition induction and chemoresistance. Scientific Reports. 12(1). 22496–22496. 4 indexed citations
5.
Huang, Lin, et al.. (2021). TRIM14 regulates melanoma malignancy via PTEN/PI3K/AKT and STAT3 pathways. Aging. 13(9). 13225–13238. 18 indexed citations
6.
Liu, Shiqi, et al.. (2021). Loss of PR55α promotes proliferation and metastasis by activating MAPK/AKT signaling in hepatocellular carcinoma. Cancer Cell International. 21(1). 107–107. 5 indexed citations
7.
Liu, Jian, Min Jiang, Quan Jin, et al.. (2021). Modulation of HMGB1 Release in APAP-Induced Liver Injury: A Possible Strategy of Chikusetsusaponin V Targeting NETs Formation. Frontiers in Pharmacology. 12. 723881–723881. 21 indexed citations
9.
Jiang, Min, Ben‐Wen Cui, Yan‐Ling Wu, et al.. (2020). P2X7R orchestrates the progression of murine hepatic fibrosis by making a feedback loop from macrophage to hepatic stellate cells. Toxicology Letters. 333. 22–32. 24 indexed citations
10.
Zhang, Zhimin, Xiaojuan Lian, Quan Jin, et al.. (2020). Role of PARP1-mediated autophagy in EGFR-TKI resistance in non-small cell lung cancer. Scientific Reports. 10(1). 20924–20924. 12 indexed citations
11.
Wang, Fan, et al.. (2020). Ellagic acid inhibits cell proliferation, migration, and invasion in melanoma via EGFR pathway.. PubMed. 12(5). 2295–2304. 18 indexed citations
12.
Jin, Quan, Chunping Qiao, Jianbin Li, Juan Li, & Xiao Xiao. (2019). An engineered serum albumin-binding AAV9 capsid achieves improved liver transduction after intravenous delivery in mice. Gene Therapy. 27(5). 237–244. 8 indexed citations
13.
Bulaklak, Karen, Bin Xiao, Chunping Qiao, et al.. (2018). MicroRNA-206 Downregulation Improves Therapeutic Gene Expression and Motor Function in mdx Mice. Molecular Therapy — Nucleic Acids. 12. 283–293. 22 indexed citations
14.
Zhang, Wei, Quan Jin, Jing Luo, Jinhong Wu, & Zhengwu Wang. (2018). Phytonutrient and anti-diabetic functional properties of flavonoid-rich ethanol extract from Angelica Keiskei leaves. Journal of Food Science and Technology. 55(11). 4406–4412. 14 indexed citations
15.
Shang, Yue, Xifeng Li, Ying Li, et al.. (2018). Leucodin attenuates inflammatory response in macrophages and lipid accumulation in steatotic hepatocytes via P2x7 receptor pathway: A potential role in alcoholic liver disease. Biomedicine & Pharmacotherapy. 107. 374–381. 24 indexed citations
16.
Qiao, Chunping, Yi Dai, Viktoriya D. Nikolova, et al.. (2018). Amelioration of Muscle and Nerve Pathology in LAMA2 Muscular Dystrophy by AAV9-Mini-Agrin. Molecular Therapy — Methods & Clinical Development. 9. 47–56. 18 indexed citations
17.
Li, Xia, Quan Jin, Yan‐Ling Wu, et al.. (2016). Tetrandrine regulates hepatic stellate cell activation via TAK1 and NF-κB signaling. International Immunopharmacology. 36. 263–270. 26 indexed citations
18.
Bai, Ting, Youli Yao, Xuejun Jin, et al.. (2014). Acanthoic acid, a diterpene in Acanthopanax koreanum, ameliorates the development of liver fibrosis via LXRs signals. Chemico-Biological Interactions. 218. 63–70. 20 indexed citations
19.
Jin, Quan, Shuang Jiang, Yan‐Ling Wu, et al.. (2013). Hepatoprotective effect of cryptotanshinone from Salvia miltiorrhiza in d-galactosamine/lipopolysaccharide-induced fulminant hepatic failure. Phytomedicine. 21(2). 141–147. 38 indexed citations
20.
Lian, Li‐Hua, Quan Jin, Yan‐Ling Wu, et al.. (2013). Ginsenoside Rh2 Downregulates LPS-Induced NF-κB Activation through Inhibition of TAK1 Phosphorylation in RAW 264.7 Murine Macrophage. Evidence-based Complementary and Alternative Medicine. 2013. 1–8. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026